Amarin buys Israeli firm in €22m deal

IRISH pharmaceutical company Amarin is to buy an Israeli firm in a deal worth up to $32 million (€21.7m).

Amarin buys Israeli firm in €22m deal

Amarin, which is backed by a number of former Elan executives, will initially pay €10.2m for Ester Neurosciences.

The Israeli firm is working on drugs to treat a range of neurodegenerative and inflammatory diseases.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited